Many risk factors have been identified in @entity259 , with them, some prognostic scores have been designed to asign the risk of recurrence and survival. In Mexican population, this type of study is scarce. This is a retrospective review of 180 @entity1 with @entity259 completely treated at the @entity580 , IMSS, in Mexico City from 1980 to 1990. All prognostic factors were analyzed and a score obtained either by the method of AGES, MACIS, or SKMH. Correlation of recurrences and survival was carried out according to score or risk assignment. There was a predominance of females (4.8:1), 48% had metastatic cervical nodes, median @entity5 size was 4 cm, 16% had multiple macroscopic @entity259 , in 12% resection was incomplete, 96% were papillary, and 4% follicular @entity5 . According to AGES, 46% were high risk @entity1 , 49.4% with MACIS and 45.5% with SKMH, respectively. Median follow-up was 8.3 years. There were 67 (37%) recurrences. Ten-year overall survival was 89.4% and disease-free survival was 79.2%. There was no statistical significant difference of survival of AGES until the score reached 6 or more or the MACIS score reached 8 or more. Cox multivariate model showed that above the age of 45, @entity5 size of 5 cm or more, follicular histology, multiple macroscopic @entity259 , and extracapsular node invasion affected ten-year survival. In conclusions our @entity1 are diagnosed at more advanced stages than @entity1 in the U.S. or European countries. Nearly one half of our @entity1 belonged to the high-risk group. This study confirms that @entity1 over the age of 45, @entity5 size > 5 cm, and follicular histology are adverse prognostic factors and report that extracapsular node invasion and multiple macroscopic @entity259 are also adverse prognostic factors. In Mexican population, with 50% of high-risk @entity1 , AGES and MACIS scores reached statistical differences with higher qualifications than observed in the U.S.

Multifactorial analysis of survival and recurrences in XXXX . Comparative evaluation of usefulness of AGES, MACIS, and risk group scores in Mexican population.

@entity1 :: ('9606', 'Species') :: ['patients'] @entity259 :: ('MESH:D013964', 'Disease') :: ['thyroid tumors', 'differentiated thyroid cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'cancers'] @entity580 :: ('MESH:D003428', 'Disease') :: ['Hospital de Oncologia']
@entity259 :: (MESH:D013964,Disease) :: ['differentiated thyroid cancer']
